The scenario of chronic kidney disease (CKD) management has been transformed by the advent of sodium glucose co-transporter-2 ...

There is lower risk for mortality in patients with cardio-renal-metabolic multimorbidity who maintain hematologic parameters within optimal ranges.

Black Diamonds shares surge 86.4% in 2025 as strong silevertinib data and rising estimates fuel optimism for further gains.

Objectives: This study aimed to evaluate the effectiveness of value-based care (VBC) interventions in slowing the progression of chronic kidney disease (CKD), as measured by changes in estimated ...

A cover picture of a Luton Carnival reveller presents an undesirable form of exposure for the local authority’s draft town ...

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

Hypoxia, or low oxygen in the body, is common in solid tumors. Now, researchers have identified that an RNA molecule, EUDAL, ...

Iron therapies, erythropoiesis stimulating agents (ESAs), and hypoxia inducible factor inhibitors (HIF-PHI) are used to treat anemia of chronic kidney disease (CKD).

In hypoxia, the RNA molecule EUDAL keeps EGFR permanently active. This activates the STAT3/BNIP3 pathway, triggering ...

The global market for managing EGFR inhibitors induced skin disorders is expanding due to increased awareness and the growing use of EGFR-targeted cancer therapies. These inhibitors, crucial for ...

Genmab acquires Merus for $8B, boosting cancer drug pipeline with petosemtamab. Check out what this deal means for GMAB and ...

Investigators assessed markers of chronic kidney disease (CKD) with cancer risks using data from more than one million patients.